Form 4 for KLRS Kalaris Therapeutics, Inc.

Accepted 2023-01-23 00:00:00 ET · period of report 2023-01-19 · accession 0001209191-23-004501 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
I	2023-01-23	2022-12-02	KLRS	Miller Edward	GC	G - Gift	$0.00	+98.3K	288.8K	+52%	$0
	2023-01-23	2022-12-02	KLRS	Miller Edward	GC	G - Gift	$0.00	-98.3K	151.0K	-39%	$0
M	2023-01-23	2023-01-19+	KLRS	Miller Edward	GC	S - Sale	$5.09	-2,573	148.5K	-2%	-$13.1K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2022-12-02	G	A	98,346	$0.00	288,799	I	—	—
2	Common	Common Stock	2022-12-02	G	D	98,346	$0.00	151,031	D See footnote	—	—	(F2) Shares held by The Miller Family 2019 Irrevocable Dynasty Trust. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
3	Common	Common Stock	2023-01-19	S	D	2,032	$5.08	148,999	D	—	—	(F4) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.94 to $5.19. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
4	Common	Common Stock	2023-01-20	S	D	541	$5.14	148,458	D	—	—	(F5) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.05 to $5.22. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.